Please ensure Javascript is enabled for purposes of website accessibility

3 More Surprising Stocks Moving Higher in 2020

By Rick Munarriz – Apr 6, 2020 at 11:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There were more than 600 stocks moving higher in the first quarter, and that includes an e-tail giant, a medical equipment specialist, and a high-tech dealmaker.

Your portfolio probably looks pretty bad right now, but it could've been worse if you didn't own any of the more than 600 stocks that moved higher through the first three months of the year. I took a look five stocks with positive returns in the first quarter, and I figured I would go over a few more of the bear-bucking winners. (AMZN -1.57%), Masimo (MASI -0.89%), and DocuSign (DOCU -3.13%) are three names that moved higher in a quarter in which the market headed sharply lower. Let's take a deeper dive into the three market beaters.

Amazon Prime Air drone in the air with clouds and blue sky behind it.

An Amazon delivery drone. Image source:


Being an online retailer is understandably better than being a brick-and-mortar chain these days. Only essential local retailers are staying open across most of the country, and folks riding out the pandemic are encouraged to lean on delivery services and online merchants to prevent having to spend too much time outside. Is it really a surprise to see Amazon shares move 6% higher in the first quarter?

Amazon was already doing a good job of giving folks lots of reasons to turn to its online platform before even considering a trip to the neighborhood strip mall. It's been building out local fulfillment centers that can deliver stocked orders in a day or two, if not within hours. Low prices are possible given its lean and tech-savvy infrastructure. With platforms like its grocery-delivering Amazon Fresh service and same-day delivery Prime Now thriving in this climate, the world's leading online retailer is resilient at the moment. It remains to be seen how healthy Amazon will be at the tail end of this crisis when the economy is on the ropes. But for now, Amazon's a winning business that stands to be on the receiving end of a lot of consumer stimulus-check spending. 


One industry that is naturally seeing an uptick in the new COVID-19 normal is hospital supplies, especially a company offering essential tools. Masimo is a leader in pulse oximetry, the noninvasive gadgetry that helps monitor a patient's blood oxygen level and heart rate. Masimo shares rose 12% through the first three months of the year, and that was before it confirmed last week that business accelerated in the first quarter. 

The company announced on April 1 that it sees product revenue rising 14.5% to 17.5% for the quarter that ended four days earlier. Product revenue had risen 12.8% in 2019, slowing to an 11.5% clip in the final quarter of the year. Masimo did recently announce that during the crisis, it will be making licenses for its rainbow-branded hardware available at no additional charge to hospitals where the devices are already in use -- in response to the current worldwide blood shortage -- a move that is more likely to boost its reputation than sting its finances.  


If Amazon's 6% gain and Masimo's 12% pop were impressive during the market deluge in the first quarter, DocuSign's 25% surge should surely turn heads. The company is the leader in electronic document and contract signatures, a niche that has gone from being a convenience to almost a formality in these social-distancing times. 

DocuSign was already riding high ahead of the health crisis. Revenue growth accelerated in fiscal 2020, climbing 39% after a 35% ascent the year before. With earnings growing even faster than its top-line bursts and DocuSign seemingly boosting its guidance with every passing quarter, momentum has been building in its favor.

These are challenging times, but investing in growth stocks becomes easier when you find businesses growing through events that are tripping up most other publicly traded companies.  

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Rick Munarriz has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Amazon, DocuSign, and Masimo and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned, Inc. Stock Quote, Inc.
$113.00 (-1.57%) $-1.80
Masimo Corporation Stock Quote
Masimo Corporation
$141.16 (-0.89%) $-1.26
DocuSign Stock Quote
$53.47 (-3.13%) $-1.73

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.